CAMBRIDGE, Mass.--(BUSINESS WIRE)--T2 Biosystems, Inc., a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance (MR) technology, today announced significant research findings that support the advancement and development of nanoparticle-based, magnetic resonance technology that offer rapid, portable diagnostic testing. The findings appear in Analytical Chemistry in an article entitled “Single-coil, Multi-sample, Proton Relaxation Method for Magnetic Relaxation Switch Assays,” available on line at www.acs.org.
